publication date: Sep. 26, 2014
The University of Colorado and Colorado State University are vying to become the first institution to build a carbon-ion radiotherapy research and treatment facility in the U.S. The treatment modality is available in Europe and Japan.
Officials at the two universities are exploring the feasibility of building a $300 million research and treatment facility at the University of Colorado Anschutz Medical Campus in Aurora.
Their first step is to conduct a $200,000 feasibility study for the project.
|Conversation with The Cancer Letter|
Pat White: NIH Funding “Our Only Concern”
A lobbying campaign will make an effort to secure an immediate, significant funding increase for NIH.
The effort, called ACT for NIH: Advancing Cures Today, seeks to bring together patients, scientists, advocates, and lawmakers on both sides of the aisle. Their objective is to demonstrate the impact of a decade of clamping down on NIH funding. Adjusted for inflation, NIH receives nearly 25 percent less funding than it did in 2003.
Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case
HOUSTON—Ana Maria Gonzalez-Angulo, a 43-year-old breast cancer specialist at MD Anderson Cancer Center, was found guilty of poisoning her lover, George Blumenschein, another medical oncologist at MD Anderson.
A jury at the Harris County 248th District Criminal Court found Gonzalez-Angulo guilty of aggravated assault Sept. 26. The court immediately went into the penalty phase of the proceedings.
“Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot
In America, cutting-edge inventions are seen as the gateway to the future. However, the hazard of credulously accepting new technology into medical practice was warned against in a 2008 Journal of the American Medical Association editorial “Gizmo Idolatry.”
The term “gizmo idolatry” describes the conviction that a high-tech approach is better than a low-tech approach, even if there’s no evidence to support that view. A glaring example of medical “gizmo idolatry” is the da Vinci Surgical System. Without credible data to prove its safety and benefit in complex surgeries, this costly robotic machine has been promoted into near ubiquitous use in hospitals across the nation.
|MD Anderson Expands Reach Into Florida, Ohio|
Two institutions said they are in varying stages of completing partnerships with MD Anderson Cancer Center.
The two deals are a part of an expansion strategy that essentially means that the MD Anderson logo can light up almost anywhere, establishing the Houston-based cancer center as a potential competitor to almost any cancer center in the U.S.
|NCI Starts “Exceptional Responders” Study|
NCI has launched a pilot study to investigate the molecular factors of tumors associated with exceptional treatment responses of cancer patients to drug therapies.
The Exceptional Responders Initiative seeks to identify the molecular features of tumors that predict whether a particular drug or class of drugs will be beneficial.
Doug Ulman named CEO of Pelotonia
Margaret Foti honored by Friends of Cancer Research
Wilshire Oncology Medical Group joins City of Hope
The West Clinic receives National Committee for Quality Assurance recognition
FDA awards Critical Path Institute $2.1 million
Beth Israel Deaconess Medical Center and Cancer Genetics Inc. enter collaboration
FASEB publishes factsheet on federal research funding by congressional district
Lisa Stockmon named City of Hope chief communications officer
FDA names recipients Drug Shortage Assistance Award
European Head and Neck Society calls for EU program
QVC and Fashion Footwear Association of New York present $240,000 to University of Pittsburgh Cancer Institute